Search Results - "Gobom, J"
-
1
Transitioning from cerebrospinal fluid to blood tests to facilitate diagnosis and disease monitoring in Alzheimer's disease
Published in Journal of internal medicine (01-09-2021)“…Alzheimer’s disease (AD) is increasingly prevalent worldwide, and disease‐modifying treatments may soon be at hand; hence, now, more than ever, there is a need…”
Get full text
Journal Article -
2
Identification of candidate cerebrospinal fluid biomarkers in parkinsonism using quantitative proteomics
Published in Parkinsonism & related disorders (01-04-2017)“…Abstract Introduction Neurodegenerative parkinsonian syndromes have significant clinical and pathological overlap, making early diagnosis difficult…”
Get full text
Journal Article -
3
α-Cyano-4-hydroxycinnamic Acid Affinity Sample Preparation. A Protocol for MALDI-MS Peptide Analysis in Proteomics
Published in Analytical chemistry (Washington) (01-02-2001)“…We present a new MALDI sample preparation technique for peptide analysis using the matrix α-cyano-4-hydroxycinnamic acid (CHCA) and prestructured sample…”
Get full text
Journal Article -
4
-
5
A CE−MALDI Interface Based on the Use of Prestructured Sample Supports
Published in Analytical chemistry (Washington) (15-04-2001)“…We have developed an off-line coupling of capillary electrophoresis (CE) to matrix-assisted laser desorption/ionization time-of-flight mass spectrometry…”
Get full text
Journal Article -
6
Identification of nuclei associated proteins by 2D-gel electrophoresis and mass spectrometry
Published in Journal of neuroscience methods (15-08-2001)“…In clinical neuroscience as well as in many other clinical disciplines, the completion of the human genome project offers a new possibility to identify and…”
Get full text
Journal Article Conference Proceeding -
7
Novel tau fragments in cerebrospinal fluid: relation to tangle pathology and cognitive decline in Alzheimer’s disease
Published in Acta neuropathologica (01-02-2019)“…Tau is an axonal microtubule-binding protein. Tau pathology in brain and increased tau concentration in the cerebrospinal fluid (CSF) are hallmarks of…”
Get full text
Journal Article -
8
Genome-scale metabolic network reconstruction of model animals as a platform for translational research
Published in Proceedings of the National Academy of Sciences - PNAS (27-07-2021)“…Genome-scale metabolic models (GEMs) are used extensively for analysis of mechanisms underlying human diseases and metabolic malfunctions. However, the lack of…”
Get full text
Journal Article -
9
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics
Published in Brain (London, England : 1878) (01-12-2020)“…Alzheimer's disease is biologically heterogeneous, and detailed understanding of the processes involved in patients is critical for development of treatments…”
Get full text
Journal Article -
10
Genome-wide meta-analysis for Alzheimer’s disease cerebrospinal fluid biomarkers
Published in Acta neuropathologica (01-11-2022)“…Amyloid-beta 42 (Aβ42) and phosphorylated tau (pTau) levels in cerebrospinal fluid (CSF) reflect core features of the pathogenesis of Alzheimer’s disease (AD)…”
Get full text
Journal Article -
11
P.621 Exploring the cerebrospinal fluid proteome in bipolar disorder
Published in European neuropsychopharmacology (01-12-2019)Get full text
Journal Article -
12
Neurogranin in cerebrospinal fluid as a marker of synaptic degeneration in Alzheimer's disease
Published in Brain research (29-11-2010)“…Abstract Synaptic pathology occurs early in Alzheimer's disease (AD) development, and cerebrospinal fluid biomarkers for synaptic damage may be altered early…”
Get full text
Journal Article -
13
Cerebrospinal fluid tau levels are associated with abnormal neuronal plasticity markers in Alzheimer's disease
Published in Molecular neurodegeneration (28-03-2022)“…Increased total tau (t-tau) in cerebrospinal fluid (CSF) is a key characteristic of Alzheimer's disease (AD) and is considered to result from…”
Get full text
Journal Article -
14
PROTEIN QUANTITATIVE TRAIT LOCI (PQTL) MAPPING OF THE CEREBROSPINAL FLUID PROTEOME
Published in EUROPEAN NEUROPSYCHOPHARMACOLOGY (01-10-2022)Get full text
Journal Article Conference Proceeding -
15
Post‐GWAS multiomic functional investigation of the TNIP1 locus in Alzheimer's disease highlights a potential role for GPX3
Published in Alzheimer's & dementia (01-07-2024)“…INTRODUCTION Recent genome‐wide association studies (GWAS) have reported a genetic association with Alzheimer's disease (AD) at the TNIP1/GPX3 locus, but the…”
Get full text
Journal Article -
16
CSF proteomic profiles of neurodegeneration biomarkers in Alzheimer's disease
Published in Alzheimer's & dementia (01-09-2024)“…INTRODUCTION We aimed to unravel the underlying pathophysiology of the neurodegeneration (N) markers neurogranin (Ng), neurofilament light (NfL), and…”
Get full text
Journal Article -
17
Optimized sample preparation and data analysis for TMT proteomic analysis of cerebrospinal fluid applied to the identification of Alzheimer's disease biomarkers
Published in Clinical proteomics (14-05-2022)“…Cerebrospinal fluid (CSF) is an important biofluid for biomarkers of neurodegenerative diseases such as Alzheimer's disease (AD). By employing tandem mass tag…”
Get full text
Journal Article -
18
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non‐Alzheimer's disease pathophysiology
Published in Alzheimer's & dementia (01-03-2023)“…Background Suspected non‐Alzheimer's disease pathophysiology (SNAP) is a biomarker concept that encompasses individuals with neuronal injury but without…”
Get full text
Journal Article -
19
Protein disulfide isomerases as CSF biomarkers for the neuronal response to tau pathology
Published in Alzheimer's & dementia (01-08-2023)“…INTRODUCTION Cerebrospinal fluid (CSF) biomarkers for specific cellular disease processes are lacking for tauopathies. In this translational study we aimed to…”
Get full text
Journal Article -
20
Differential impairment of cerebrospinal fluid synaptic biomarkers in the genetic forms of frontotemporal dementia
Published in Alzheimer's research & therapy (31-08-2022)“…Approximately a third of frontotemporal dementia (FTD) is genetic with mutations in three genes accounting for most of the inheritance: C9orf72, GRN, and MAPT…”
Get full text
Journal Article